SYNH  valuation analysis

Basics
Name: Syneos Health, Inc
Description: Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Oct 29, 2020
Market cap: $7.85B (503rd)
Sales(TTM): $4.49B (443rd)
Earnings(TTM): $191.95M (539th)

Value
FFER: 1.75*
Actual price: $75.50
* Earnings were reported Feb 18, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-03-02
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Syneos Health, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Syneos Health, Inc
"Diagnostics & Research" industry
Book / MarketCap
Syneos Health, Inc
"Diagnostics & Research" industry
Equity / Assets
Syneos Health, Inc
"Diagnostics & Research" industry